| Patientheque in Patients With a Psychosis (NCT05340348) | University Hospital, Brest | 2022-07-25 |
| iTBS Can Increase Frontal Dopamine Release in PET Dopamine Imaging. (NCT05448430) | Central South University | 2022-07-15 |
| Neurobehavioral Mechanisms of Social Isolation and Loneliness in Serious Mental Illness (NCT04940663) | Massachusetts General Hospital | 2022-07-13 |
| A Study of Elpipodect (MK-8189) in Participants With Schizophrenia (MK-8189-014) (NCT05406440) | Merck Sharp & Dohme LLC | 2022-07-12 |
| Evaluation of the Efficacy of Transcranial Magnetic Stimulation on Resistant Auditory Hallucinations in Schizophrenia (NCT06599372) | Dominique JANUEL | 2022-07-11 |
| Theta-burst rTMS in Schizophrenia to Ameliorate Negative and Cognitive Symptoms (NCT05100888) | Semmelweis University | 2022-07-11 |
| Evaluation of Physical Activity, Physical Fitness, and Quality of Life in Patients With Schizophrenia (NCT05449977) | Yeditepe University | 2022-07-06 |
| A Trial of 15 and 30 mg Doses of CVL-231 (Emraclidine) in Participants With Schizophrenia (NCT05227703) | AbbVie | 2022-07-05 |
| 7-week Study With CT-155 in People With Schizophrenia (NCT05486312) | Click Therapeutics, Inc. | 2022-07-05 |
| Adapting and Examining Collaborative Decision Skills Training Among Veterans With Serious Mental Illness (NCT04324944) | VA Office of Research and Development | 2022-07-05 |
| Context-Aware Mobile Intervention for Social Recovery in Serious Mental Illness (NCT05660070) | University of California, San Diego | 2022-07-01 |
| Exercise Target Brain Oscillations in Psychosis (NCT05338424) | University of Minnesota | 2022-07-01 |
| A Trial of 10 and 30 mg Doses of CVL-231 (Emraclidine) in Participants With Schizophrenia (NCT05227690) | AbbVie | 2022-06-30 |
| Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder (NCT05303064) | Alkermes, Inc. | 2022-06-30 |
| CBTpro: Scaling up CBT for Psychosis Using Simulated Patients and Spoken Language Technologies (NCT05127837) | University of Washington | 2022-06-28 |
| Evaluation of the Individual Early Psychoeducation Program for Schizophrenic Disorders in Inpatients (NCT05329363) | University Hospital, Tours | 2022-06-17 |
| A Clinical Study That Will Assess How Food Moves Through the Stomach and Effects Blood Glucose Levels in Subjects With Schizophrenia Taking SEP-363856 or and Prior Antipsychotic (PA) Standard (NCT05402111) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2022-06-13 |
| Luteolin for the Treatment of People With Schizophrenia (NCT05204407) | University of Maryland, Baltimore | 2022-06-13 |
| Circuitry-Guided Smoking Cessation in Schizophrenia (UH3) (NCT05276050) | The University of Texas Health Science Center, Houston | 2022-06-01 |
| Accelerated cTBS on Metabolic Dysfunction in People With Schizophrenia (NCT05358899) | Central South University | 2022-06-01 |
| A Long-term Administration Trial of Brexpiprazole Once-weekly (QW) Formulation in Patients With Schizophrenia (NCT05326347) | Otsuka Pharmaceutical Co., Ltd. | 2022-05-31 |
| Community Reinforcement and Family Training for Early Psychosis (CRAFT-EP) and Substance Use: A Pilot Study (NCT05380583) | Mclean Hospital | 2022-05-19 |
| A Clinical Trial to Evaluate the Long-term Safety and Tolerability of SEP-363856 in Patients With Schizophrenia in Japan (NCT05359081) | Sumitomo Pharma Co., Ltd. | 2022-05-16 |
| Cognitive and Balance Dual Task Training for People With Schizophrenia (NCT05341804) | Kaohsiung Medical University Chung-Ho Memorial Hospital | 2022-05-10 |
| Is Cognitive Training an Option? (NCT05352568) | Alliant International University | 2022-05-02 |
| Effect of Virtual Reality-based Therapy on Negative Symptoms in People with Schizophrenia (NCT06588270) | Hospital de la Florida Dra. Eloiza Diaz | 2022-05-02 |
| Effects of Buspirone Combined With Clozapine (NCT06906224) | Chuanfu Song | 2022-05-01 |
| Rituximab Treatment for Psychosis And/or Obsessive Compulsive Disorder with Probable Immune System Involvement (NCT04323566) | Uppsala University Hospital | 2022-05-01 |
| Can Neural Network Instability in Schizophrenia be Improved With a Very Low Carbohydrate Ketogenic Diet? (NCT05268809) | Northern California Institute of Research and Education | 2022-04-21 |
| Effect of Simulation on Emotional Expression and Perceived Family Burden of Caregivers (NCT06723977) | Eskisehir Osmangazi University | 2022-04-20 |
| Efficiency Assessment of BREFORM. A Multicentric Stepped-wedge Randomized Control Trial. (NCT05036590) | Hôpital le Vinatier | 2022-04-05 |
| Sleep, Obesity and Mental Disease - Biological Markers for the Evaluation of Circadian Rhythmicity (NCT05413486) | Esbjerg Hospital - University Hospital of Southern Denmark | 2022-04-04 |
| Exploratory Study of a Digital Therapeutics in People With Schizophrenia (NCT05438160) | Click Therapeutics, Inc. | 2022-03-31 |
| Program for the Introduction Into Clinical Practice of the Principles of Personalized and Preventive Medicine Based on the Isolation of Gene Polymorphism in Schizophrenia in People of the Kazakh Ethnic Group (NCT05090644) | Asfendiyarov Kazakh National Medical University | 2022-03-30 |
| Evaluation of the Role of Neurodegeneration in Schizophrenia (NCT05257720) | Istanbul Saglik Bilimleri University | 2022-03-28 |
| Effect of Nicotine Transdermal Patch on Cognitive Function and Glycolipid Metabolism in Non-smoking Schizophrenia (NCT05301660) | Sir Run Run Shaw Hospital | 2022-03-22 |
| Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial (NCT05208190) | New York State Psychiatric Institute | 2022-03-17 |
| Academic-Community EPINET (AC-EPINET) (NCT04497857) | Indiana University | 2022-03-16 |
| Sodium Nitroprusside in Early Course Schizophrenia (NCT04986072) | Beth Israel Deaconess Medical Center | 2022-03-14 |
| Medication Reviews in Severe Mental Illness (NCT05243160) | Psychiatric Research Unit, Region Zealand, Denmark | 2022-03-11 |
| An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia (NCT05304767) | Karuna Therapeutics, Inc., a Bristol Myers Squibb company | 2022-03-07 |
| Antipsychotic Effects of Probiotics and Prebiotics on Patients With Schizophrenia (NCT04291469) | First Affiliated Hospital Xi'an Jiaotong University | 2022-03-03 |
| A Clinical Trial to Evaluate Safety, Tolerance and Pharmacokinetics of JX11502MA Capsule in Patients With Schizophrenia. (NCT06356389) | Zhejiang Jingxin Pharmaceutical Co., Ltd. | 2022-03-02 |
| CLOZAPINE Response in Biotype-1 (NCT04580134) | University of Texas Southwestern Medical Center | 2022-03-01 |
| Real-time fMRI Neurofeedback in Patients With Schizophrenia and Auditory Hallucinations (NCT05299749) | Boston VA Research Institute, Inc. | 2022-03-01 |
| Psychological Interventions for Complex PTSD And Schizophrenia-Spectrum Disorder: PICASSO Trial (NCT05281640) | Edinburgh Napier University | 2022-02-28 |
| Combination of NMDA-enhancing and Anti-inflammatory Treatments for Ultra-resistant Schizophrenia (NCT05240976) | China Medical University Hospital | 2022-02-23 |
| Study of the Effectiveness of Mental Contrasting and Implementation Intention in the Management of Apathy in Schizophrenia (NCT04781179) | University Hospital, Montpellier | 2022-02-22 |
| Synbiotic Compound to Reduce Symptoms of Schizophrenia (NCT04226898) | Sheppard Pratt Health System | 2022-02-21 |
| Assessment of the Efficacy of a Fatigue Management Therapy in Schizophrenia (NCT04332601) | University Hospital, Montpellier | 2022-02-01 |
| Evaluate the Safety, Tolerability and Pharmacokinetic Profile of TPN672 Tablets Maleate in Patients With Schizophrenia (NCT05192304) | Jiangsu Kanion Pharmaceutical Co., Ltd | 2022-02-01 |
| The Effect of Developing Psychological Resilience on Functionality in Schizophrenia Patients (NCT05739344) | Sisli Hamidiye Etfal Training and Research Hospital | 2022-02-01 |
| Impact of Structural and Myelin Abnormalities on Cognitive Impairments in Recent-onset Schizophrenia - Before and After Lurasidone Treatment (MARYLU) (NCT05351736) | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 2022-01-26 |
| Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia (NCT05184335) | Reviva Pharmaceuticals | 2022-01-24 |
| Trial to Study the Effect of CVL-231 on 24-Hour Ambulatory Blood Pressure in Participants With Schizophrenia (NCT05245539) | Cerevel Therapeutics, LLC | 2022-01-24 |
| Prevalence of Cardiovascular Disorders in Patients Aged 40 and More With Schizophrenia (NCT05174533) | Université de Reims Champagne-Ardenne | 2022-01-12 |
| Cognitive Remediation for Social Cognition in Schizophrenia and Related Disorders (NCT05017532) | Douglas Mental Health University Institute | 2022-01-06 |
| Risk of Mental Health Conditions in Children and Young Adults With Inflammatory Bowel Disease and Influence on Health (NCT05206734) | Momentum Data | 2022-01-05 |
| Home-based Intervention With Semaglutide Treatment Of Neuroleptica-Related Prediabetes (NCT05193578) | Jan Frystyk | 2022-01-01 |
| European Long-acting Antipsychotics in Schizophrenia Trial-II (NCT05165316) | Rene Kahn | 2021-12-31 |
| Study of the Impact on the Therapeutic Alliance of a Short Initial Psychoeducation Programme in Patients With Early Schizophrenia (NCT04867681) | Centre Hospitalier Universitaire de Nice | 2021-12-08 |
| Study to Evaluate the Efficacy, Safety, and Tolerability of Luvadaxistat in Participants With Cognitive Impairment Associated With Schizophrenia (NCT05182476) | Neurocrine Biosciences | 2021-12-07 |
| State Representation in Early Psychosis (NCT05273164) | University of Minnesota | 2021-12-01 |
| Mental Health During the Whole Life Cycle of Community Patients With Schizophrenia (NCT05159349) | Shanghai Mental Health Center | 2021-12-01 |
| Cognitive Remediation Method by Rhythmic, Vocal and Embodied Musical Learning for Stabilized Schizophrenic Patients (NCT05124470) | University Hospital, Toulouse | 2021-12-01 |
| Risk Prediction Model of Cardiovascular Events in Patients With Schizophrenia (NCT05498571) | Shanghai Mental Health Center | 2021-12-01 |
| Comparison of Berberine and Metformin for the Treatment for MS in Schizophrenia Patients (NCT03708549) | Tianjin Anding Hospital | 2021-12-01 |
| Investigation of Community Reablement on Instrumental Activities of Daily Living in People With Schizophrenia (NCT04350775) | National Taipei University of Nursing and Health Sciences | 2021-11-30 |
| Journey Study: Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as Adjunctive Treatment for Schizophrenia (NCT05110157) | Neurocrine Biosciences | 2021-11-29 |
| A Clinical Pharmacology Trial of Brexpiprazole Long Acting Injectable (LAI) Administered as a Single Dose in Patients With Schizophrenia (NCT05119894) | Otsuka Pharmaceutical Co., Ltd. | 2021-11-22 |
| cTBS on First-episode Drug Naive Patients With Schizophrenia (NCT05086133) | Central South University | 2021-11-20 |
| Study Evaluating the Efficacy and Safety of WID-RGC20(Cariprazine) in Patients With Schizophrenia (NCT05168007) | Whanin Pharmaceutical Company | 2021-11-19 |
| Neurotransmitters in Treatment Resistant Schizophrenia Patients With add-on Sodium Benzoate (NCT06340789) | National Cheng-Kung University Hospital | 2021-11-18 |
| Transcranial Alternating Current Stimulation (tACS) for Auditory Hallucinations (NCT05159336) | Shanghai Mental Health Center | 2021-11-16 |
| A Study to Assess Efficacy and Safety of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia (NCT05145413) | Karuna Therapeutics, Inc., a Bristol Myers Squibb company | 2021-11-12 |
| Using Speech to Monitor Symptom Severity in Arabic Speaking Patients With Schizophrenia (NCT05563818) | Hikma Pharmaceuticals LLC | 2021-11-09 |
| Enhancing Prefrontal Oscillations and Working Memory in Early-course Schizophrenia (NCT05102929) | Fabio Ferrarelli | 2021-11-05 |
| Aripiprazole Once-Monthly in Hospitalized Patients (INITIATE) (NCT04907279) | Otsuka Canada Pharmaceutical Inc. | 2021-11-01 |
| Targeting Individual Alpha Frequencies to Enhance Perceptual Timing (NCT04856657) | University of Minnesota | 2021-11-01 |
| Neurofilament Light Chains and Cognitive Impairment in Chronic Psychiatric Disease (NCT04946916) | Hôpital le Vinatier | 2021-10-22 |
| Mobile Self-Tracking of Mental Health (NCT05023252) | VA Office of Research and Development | 2021-10-18 |
| Virtual Reality Training for Social Skills in Schizophrenia - Comparison With Cognitive Training (NCT04005794) | Vanderbilt University | 2021-10-15 |
| Using Transcranial Magnetic Stimulation (TMS) to Understand Hallucinations in Schizophrenia (NCT05343598) | Mclean Hospital | 2021-10-13 |
| Time Prediction and Cerebellum: Magnetic Transcranial Stimulation (TMS) in Healthy Volunteers (NCT04300946) | University Hospital, Strasbourg, France | 2021-10-10 |
| Translational Investigation of the Glutamatergic and GABAergic System in Schizophrenia (NCT04655235) | RWTH Aachen University | 2021-10-01 |
| The Effects of Different Modalities of Exercise in Patients With Schizophrenia (NCT04987151) | Cardenal Herrera University | 2021-10-01 |
| Neurocognition After Perturbed Sleep (NCT05032963) | Icahn School of Medicine at Mount Sinai | 2021-09-21 |
| Comparing Two Behavioral Approaches to Quitting Smoking in Mental Health Settings (NCT05030272) | Wake Forest University Health Sciences | 2021-09-21 |
| Does tDCS Change Synaptic Density in the Brains of Patients With Schizophrenia (NCT05435300) | Centre for Addiction and Mental Health | 2021-09-17 |
| Brain Stimulation, Clinical Symptoms and Cognition (NCT05053451) | University of California, Davis | 2021-09-14 |
| A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia (NCT05039489) | Central South University | 2021-09-09 |
| Brain Stimulation and Cognitive Training - Efficacy (NCT05111548) | University of Michigan | 2021-09-08 |
| Clinical Trial of Iclepertin Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-1) (NCT04846868) | Boehringer Ingelheim | 2021-09-08 |
| Does GLP-1RA Prevent Deterioration of Metabolic State in Prediabetic and Diabetic Patients Treated With Antipsychotic Medication? (NCT04892199) | Anders Fink-Jensen, MD, DMSci | 2021-09-01 |
| Resting State Electroencephalogram for Psychotic Disorders (NCT05065489) | Central South University | 2021-09-01 |
| Assessing a WeChat-based Integrative Family Intervention (WIFI) for Schizophrenia (NCT04393896) | Xiangya Hospital of Central South University | 2021-09-01 |
| Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder (NCT05025605) | BioXcel Therapeutics Inc | 2021-08-27 |
| Clinical Trial of Iclepertin Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-2) (NCT04846881) | Boehringer Ingelheim | 2021-08-24 |
| Neural Correlates of Social Touch and Interoceptive Perception As Potential Biomarker for Impaired Social Functioning (NCT04968223) | University of Oldenburg | 2021-08-16 |
| The Safety and Efficacy of Lurasidone With Different Initiation Dose in Chinese Acute Phase Patients With Schizophrenia (NCT05011669) | Marubeni Pharmaceuticals (Suzhou) Co., Ltd. | 2021-08-16 |